Skip to main content

Raymond W. Anderson, MBA

Equibles does not estimate personal net worth.

About Raymond W. Anderson, MBA

Raymond W. Anderson, MBA is recorded as Board Member at Monopar Therapeutics (MNPR) since June 28, 2022. Monopar Therapeutics is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Monopar Therapeutics includes Chandler D. Robinson (CEO and Board Member), Karthik Radhakrishnan (CFO and Chief Accounting Officer), Quan A. Vu (CFO) and 7 others.

Affiliation history

Company network

Leadership on record at Monopar Therapeutics

Recent activity

No call appearances or filed executive changes recorded yet.